Subtitle
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
Subtitle
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
Proto therapy Time
May 2023
Executive summary
This study reported outcomes of 194 patients diagnosed with IDH-mutated WHO grade 2 (n = 128) and WHO grade 3 (n = 66) glioma treated with proton radiation. With a median follow-up 5.1 years, 5-year OS was 85% for WHO grade 2 patients and 67% WHO grade 3. AEs of 80% grade 1, 7% grade 2, 13% grade 3, and 0% grade 3+ were observed. The authors concluded that these results demonstrated the effectiveness of PRT for IDH-mutated glioma WHO grade 2 and 3.
Top cancer treatments
Related contents
Proton Therapy Publication
March 2024
How proton therapy fits into the management of adult intracranial tumors.
Proton Therapy Publication
March 2024
Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Proton Therapy Publication
March 2024
Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma.
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group.
Proton Therapy Publication
January and February 2023
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma.
Proton Therapy Publication
January and February 2023
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.
Proton Therapy Publication
December 2023
Comparison of the Effectiveness of Radiotherapy with 3D-CRT, IMRT, VMAT and PT for Newly Diagnosed Glioblastoma: A Bayesian Network Meta-Analysis.
Proton Therapy Publication
September and October 2023
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
Proton Therapy Publication
September and October 2023
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients.